121 related articles for article (PubMed ID: 2931434)
1. Primary structure of single-chain pro-urokinase.
Kasai S; Arimura H; Nishida M; Suyama T
J Biol Chem; 1985 Oct; 260(22):12382-9. PubMed ID: 2931434
[TBL] [Abstract][Full Text] [Related]
2. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.
Kasai S; Arimura H; Nishida M; Suyama T
J Biol Chem; 1985 Oct; 260(22):12377-81. PubMed ID: 3930494
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
[TBL] [Abstract][Full Text] [Related]
4. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.
Ichinose A; Fujikawa K; Suyama T
J Biol Chem; 1986 Mar; 261(8):3486-9. PubMed ID: 3081506
[TBL] [Abstract][Full Text] [Related]
5. The complete amino acid sequence of low molecular mass urokinase from human urine.
Steffens GJ; Günzler WA; Otting F; Frankus E; Flohé L
Hoppe Seylers Z Physiol Chem; 1982 Sep; 363(9):1043-58. PubMed ID: 6754572
[TBL] [Abstract][Full Text] [Related]
6. Covalent molecular weight approximately 92 000 hybrid plasminogen activator derived from human plasmin amino-terminal and urokinase carboxyl-terminal domains.
Robbins KC; Tanaka Y
Biochemistry; 1986 Jun; 25(12):3603-11. PubMed ID: 2941075
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
Kobayashi H; Schmitt M; Goretzki L; Chucholowski N; Calvete J; Kramer M; Günzler WA; Jänicke F; Graeff H
J Biol Chem; 1991 Mar; 266(8):5147-52. PubMed ID: 1900515
[TBL] [Abstract][Full Text] [Related]
8. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
Liu JN; Pannell R; Gurewich V
J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of activation of rabbit plasminogen by urokinase.
Sodetz JM; Castellino FJ
J Biol Chem; 1975 Apr; 250(8):3041-9. PubMed ID: 123529
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic properties of an inactive proenzyme form of human urokinase secreted from human kidney cells.
Kasai S; Arimura H; Nishida M; Suyama T
Cell Struct Funct; 1985 Jun; 10(2):151-9. PubMed ID: 3924420
[TBL] [Abstract][Full Text] [Related]
13. Activation of plasminogen by pro-urokinase. II. Kinetics.
Collen D; Zamarron C; Lijnen HR; Hoylaerts M
J Biol Chem; 1986 Jan; 261(3):1259-66. PubMed ID: 2935529
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D
Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477
[TBL] [Abstract][Full Text] [Related]
15. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
Liu JN; Gurewich V
Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
[TBL] [Abstract][Full Text] [Related]
16. Selenium-dependent glutathione peroxidases from ovine and bovine erythrocytes occur as longer chain forms than previously recognized.
Gettins P; Dyal D; Crews B
Arch Biochem Biophys; 1992 May; 294(2):511-8. PubMed ID: 1567207
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
Stump DC; Lijnen HR; Collen D
J Biol Chem; 1986 Dec; 261(36):17120-6. PubMed ID: 3097021
[TBL] [Abstract][Full Text] [Related]
18. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
[TBL] [Abstract][Full Text] [Related]
19. Human tumor cell urokinase-type plasminogen activator (uPA): degradation of the proenzyme form (pro-uPA) by granulocyte elastase prevents subsequent activation by plasmin.
Schmitt M; Kanayama N; Jänicke F; Hafter R; Graeff H
Adv Exp Med Biol; 1991; 297():111-28. PubMed ID: 1837419
[TBL] [Abstract][Full Text] [Related]
20. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
